Health-care companies fell sharply as one of the strongest sectors in 2022 continued a fall from grace.
Protagonist Therapeutics shares rallied after the company said a treatment showed promise in a clinical trial on patients suffering from plaque psoriasis.
Shares of biotech concern Cara Therapeutics tumbled after it posted a quarterly loss.
Apotex and Pharmedica have each recalled eye-drop products, citing the danger of causing infections and other problems.
The parent of diet-plan company WeightWatchers soared after it agreed to buy telehealth company Sequence, seeking to distribute new obesity drugs.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
03-07-23 1724ET
